栄研化学の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2021/12/23 | 1,924 | 1,931 | 1,906 | 1,921 | +5 | +0.3% | 67,600 |
2021/12/22 | 1,919 | 1,919 | 1,890 | 1,916 | +6 | +0.3% | 74,000 |
2021/12/21 | 1,928 | 1,930 | 1,908 | 1,910 | +5 | +0.3% | 83,600 |
2021/12/20 | 1,905 | 1,919 | 1,893 | 1,905 | -11 | -0.6% | 131,300 |
2021/12/17 | 1,920 | 1,924 | 1,905 | 1,916 | -12 | -0.6% | 129,300 |
2021/12/16 | 1,934 | 1,940 | 1,912 | 1,928 | +3 | +0.2% | 115,800 |
2021/12/15 | 1,911 | 1,931 | 1,910 | 1,925 | +15 | +0.8% | 59,300 |
2021/12/14 | 1,947 | 1,954 | 1,899 | 1,910 | -36 | -1.8% | 118,100 |
2021/12/13 | 1,966 | 1,974 | 1,941 | 1,946 | -10 | -0.5% | 61,400 |
2021/12/10 | 1,960 | 1,980 | 1,950 | 1,956 | +12 | +0.6% | 112,700 |
2021/12/09 | 1,959 | 1,964 | 1,931 | 1,944 | -24 | -1.2% | 136,900 |
2021/12/08 | 1,969 | 1,981 | 1,960 | 1,968 | -1 | -0.1% | 98,300 |
2021/12/07 | 1,927 | 1,970 | 1,916 | 1,969 | +63 | +3.3% | 129,900 |
2021/12/06 | 1,917 | 1,934 | 1,903 | 1,906 | -25 | -1.3% | 119,300 |
2021/12/03 | 1,919 | 1,937 | 1,905 | 1,931 | +22 | +1.2% | 162,800 |
2021/12/02 | 1,897 | 1,925 | 1,897 | 1,909 | +9 | +0.5% | 240,700 |
2021/12/01 | 1,894 | 1,911 | 1,872 | 1,900 | +7 | +0.4% | 160,000 |
2021/11/30 | 1,926 | 1,939 | 1,882 | 1,893 | -18 | -0.9% | 239,200 |
2021/11/29 | 1,911 | 1,953 | 1,902 | 1,911 | +32 | +1.7% | 305,100 |
2021/11/26 | 1,888 | 1,893 | 1,871 | 1,879 | -8 | -0.4% | 113,600 |
2021/11/25 | 1,893 | 1,900 | 1,876 | 1,887 | +3 | +0.2% | 79,100 |
2021/11/24 | 1,884 | 1,901 | 1,882 | 1,884 | -4 | -0.2% | 116,000 |
2021/11/22 | 1,885 | 1,896 | 1,872 | 1,888 | ±0 | ±0% | 87,100 |
2021/11/19 | 1,890 | 1,892 | 1,875 | 1,888 | +7 | +0.4% | 90,600 |
2021/11/18 | 1,909 | 1,909 | 1,874 | 1,881 | -25 | -1.3% | 122,700 |
2021/11/17 | 1,911 | 1,914 | 1,893 | 1,906 | -13 | -0.7% | 85,900 |
2021/11/16 | 1,927 | 1,933 | 1,919 | 1,919 | -5 | -0.3% | 96,800 |
2021/11/15 | 1,937 | 1,945 | 1,923 | 1,924 | +4 | +0.2% | 95,900 |
2021/11/12 | 1,883 | 1,920 | 1,883 | 1,920 | +32 | +1.7% | 182,300 |
2021/11/11 | 1,884 | 1,896 | 1,877 | 1,888 | -2 | -0.1% | 113,300 |
2021/11/10 | 1,874 | 1,899 | 1,872 | 1,890 | +8 | +0.4% | 80,200 |
2021/11/09 | 1,883 | 1,890 | 1,872 | 1,882 | +10 | +0.5% | 140,900 |
2021/11/08 | 1,902 | 1,907 | 1,868 | 1,872 | -35 | -1.8% | 202,500 |
2021/11/05 | 1,913 | 1,927 | 1,900 | 1,907 | -37 | -1.9% | 229,200 |
2021/11/04 | 1,962 | 1,965 | 1,926 | 1,944 | -6 | -0.3% | 185,100 |
2021/11/02 | 1,941 | 1,952 | 1,932 | 1,950 | ±0 | ±0% | 171,700 |
2021/11/01 | 1,944 | 1,950 | 1,920 | 1,950 | +40 | +2.1% | 183,600 |
2021/10/29 | 1,911 | 1,946 | 1,901 | 1,910 | +10 | +0.5% | 249,700 |
2021/10/28 | 1,920 | 1,930 | 1,881 | 1,900 | -101 | -5% | 532,400 |
2021/10/27 | 2,000 | 2,015 | 1,986 | 2,001 | +27 | +1.4% | 270,100 |
2021/10/26 | 1,982 | 1,987 | 1,970 | 1,974 | -4 | -0.2% | 184,900 |
2021/10/25 | 1,980 | 1,981 | 1,963 | 1,978 | -6 | -0.3% | 131,400 |
2021/10/22 | 1,974 | 1,999 | 1,973 | 1,984 | +9 | +0.5% | 89,800 |
2021/10/21 | 1,995 | 1,999 | 1,971 | 1,975 | -20 | -1% | 166,500 |
2021/10/20 | 2,003 | 2,015 | 1,991 | 1,995 | +9 | +0.5% | 171,300 |
2021/10/19 | 1,936 | 1,990 | 1,933 | 1,986 | +54 | +2.8% | 245,700 |
2021/10/18 | 1,952 | 1,954 | 1,919 | 1,932 | -10 | -0.5% | 139,900 |
2021/10/15 | 1,924 | 1,943 | 1,910 | 1,942 | +40 | +2.1% | 94,000 |
2021/10/14 | 1,908 | 1,914 | 1,888 | 1,902 | -13 | -0.7% | 138,900 |
2021/10/13 | 1,920 | 1,930 | 1,911 | 1,915 | +3 | +0.2% | 159,200 |
701~
750
件表示中 / 6826件
類似銘柄と比較する
現在ご覧いただいている「栄研化」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
栄研化 | 232,200円 | +0.4% | -8.4% | 2.28% | 17.95倍 | 1.76倍 |
|
臨床検査薬大手。便潜血検査試薬(FIT)はシェア7割。尿検査(ウロ)、遺伝子検査も育成 |
ネクセラファーマ | 121,300円 | +197.7% | - | 0.00% | 49.57倍 | 1.58倍 |
|
創薬ベンチャー老舗。買収で成長。英国の創薬事業に日本が柱の後期治験・製造販売事業加わる |
杏林製薬 | 151,800円 | +3.2% | +4.5% | 3.43% | 17.44倍 | 0.67倍 |
|
医薬中堅。柱のぜんそく薬、呼吸器アレルギー薬は下期に比重。消化器領域育成。後発品も |
JCRファーマ | 67,900円 | -3.7% | -36.7% | 2.95% | 23.03倍 | 1.51倍 |
|
ヒト成長ホルモン製剤が主力、バイオ後続品も成長。希少疾病のバイオ新薬開発にも取り組む |
サンバイオ | 101,300円 | - | - | 0.00% | - | 51.01倍 |
|
脳疾患向け再生細胞薬の開発・製造・販売目指すバイオベンチャー。米国で創業し日本に逆上陸 |
市場注目の銘柄
チャート関連のコラム